Perpetua Medical AB (publ)
The answer first
Does Perpetua Medical beat the market?
No, Perpetua Medical has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 12% of Nordic stocks
- Quality7
- Value77
- Trend4
No. 156 of 195 in healthcare
Max for seven days
Follow Perpetua Medical with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Perpetua Medical
Your first answer is free, no account needed.
Do you own Perpetua Medical, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Perpetua Medical and a few more. Free, no card.
Super Stock+46.4%In short
- Perpetua Medical has fallen 65.6% over the past year, including dividends.
- Overall, Perpetua Medical ranks better than 12% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 99.6%. The price is 99.6% below its peak now.
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 12% of Nordic stocks.
No. 156 of 195 in healthcare
Low Weaker accounts than most: low profitability, high debt or uneven results.
No. 188 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.74
- Asset turnoverSales divided by everything the company owns0.34
- Return on equityProfit divided by equity+2.1%
- Cash conversionOperating cash flow divided by profit−18.60
The ranking is built on equity ratio, ROA and how steadily profit grows.
High Low price: you pay little for what the company earns and owns.
No. 14 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity0.9
- P/SPrice divided by sales0.8
- P/EPrice divided by earnings43.5
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
Low Headwind in the share price: it has done worse than most over the last year.
No. 178 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−43.3%
- 6 months−47.8%
- 9 months−49.7%
- 12 months−65.6%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
About Perpetua Medical
Perpetua Medical AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. By market value, Perpetua Medical is number 129 of 137 companies in healthcare on Nasdaq Stockholm. Perpetua Medical has not paid a dividend in the past twelve months. Of the three measures in the ranking, Perpetua Medical is strongest on value, better than 77% of Nordic stocks. The share trades in SEK. It has around 12 employees.
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. It provides DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company formerly known as Pharmacolog i Uppsala AB (publ) and changed its name to Perpetua Medical AB (publ) in April 2024. Perpetua Medical AB (publ) was incorporated in 2007 and is headquartered in Uppsala, Sweden.


See the full analysis of Perpetua Medical.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card